Abstract
Three experiments were conducted to evaluate the effect of an induced first wave persistent dominant follicle on folliculogenesis and ovulatory responses induced by FSH. On d 6 of asynchronized estrous cycle (d 0=estrus), cows were treated with a Syncromate-B implant and two injections of PGF2α (25mg, 0700h; 15mg, 1900h, i.m.). Cows in the control group retained a first-wave persistent dominant follicle, but in the aspirated group, the first-wave dominant follicle was removed via transvaginal aspiration on d 10 (d 0=estrus). Beginning on d 12, cows received 32mg of FSH-P i.m. in decreasing doses at 12-h intervals over a 4-d period. On d 15, the Syncromate-B implant was removed, and cows were ovariectomized (experiment 1, n=8) or inseminated (experiment 2, n=11) at 10 and 22h after the onset of estrus. Cows in experiment 3 received a used controlled intravaginal drug releasing (CIDR) device and two injections of PGF2α (25mg, 0700h; 15mg, 1900h; i.m.) on d 6. On d 8, the first-wave dominant follicle was aspirated (n=6) or left intact (n=5), and FSH treatment was initiated (20mg of Folltropin in decreasing doses at 12-h intervals over a 4-d period), and on d 10 the used CIDR device was removed from all cows. Ovarian follicle size and number were examined daily by ultrasonography from d 5 of the estrous cycle. The persistent dominant follicle increased in size from 10.7mm on d 5 to 15.4mm on d 10 (experiments 1 and 2), and from 9mmon d 5 to 20.4mmon d 11 (experiment 3). From d 11 to 14, the number of class 1 (2 to 5mm) follicles was lower in the aspirated group than in the control group; the number of class 2 (6 to 9mm) follicles was higher on d 12 and 13 for the aspirated group (experiments 1 and 2). The number of class 3 (≥10mm) follicles was higher in the aspirated group on d 14 to 16, but the same on d 17. Ovarian and embryo responses to superovulation did not differ between groups. In experiment 3, the numbers of class 1, 2, and 3 follicles, as well as ovarian and embryo responses following ovulation did not differ between groups. Initiation of exogenous FSH treatment appears to override any systemic inhibitory effect that a persistent dominant follicle may be exerting at the pituitary and possibly the ovary.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.